Pay in 4 interest-free payments of $5.57 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Takeda is supporting the BLA with data from the pivotal VISIBLE 2 Phase III trial, in which 409 adult patients experienced a clinical responsedefined as a decrease of 70 points or more in Crohns Disease Activity Index (CDAI) score from baselinefollowing two doses of open-label IV Entyvio
Celtarys supports drug discovery teams and academic labs by providing advanced fluorescent ligands, probes, and assay development services tailored for GPCR research, including GLP-1 receptor projects
Dose response curve for Anti-GDF8 Antibody, hFc Tag with the EC50 of 22.8 ng/ml determined by ELISA
A review article on the carnitine system can help a scientific team understand why L-Carnitine appears in metabolic-pathway literature, but it cannot document the purity or identity of a specific research lot
Tolerability: While all GLP-1s can cause gastrointestinal side effects, your tolerance may vary depending on the drug youre taking
US$ 27.64
US$ 24.71
US$ 28.72
